We are live on ! Find out more
BBH icon

VanEck Biotech ETF

101 hedge funds and large institutions have $131M invested in VanEck Biotech ETF in 2020 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 29 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $1.22M | Put options by funds: $729K

2% more capital invested

Capital invested by funds: $129M → $131M (+$2.1M)

0% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 12

0.51% less ownership

Funds ownership: 27.36%26.85% (-0.51%)

1% less funds holding

Funds holding: 102101 (-1)

17% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 29

Holders
101
Holders Change
-1
Holders Change %
-0.98%
% of All Funds
2.04%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
24
Reduced
29
Closed
12
Calls
$1.22M
Puts
$729K
Net Calls
+$487K
Net Calls Change
-$236K
Name Holding Trade Value Shares
Change
Change in
Stake
Wells Fargo
26
Wells Fargo
California
$1.07M +$102K +628 +11%
Ameriprise
27
Ameriprise
Minnesota
$1.07M +$88.1K +542 +9%
IFWM
28
Institute for Wealth Management
Colorado
$1.06M +$62K +381 +6%
SFPG
29
Stonebridge Financial Planning Group
Florida
$1.06M +$1.05M +6,485 New
RJFSA
30
Raymond James Financial Services Advisors
Florida
$1.04M +$70.1K +431 +7%
PSF
31
Pacific Sun Financial
California
$1.04M +$62.8K +386 +6%
Envestnet Asset Management
32
Envestnet Asset Management
Illinois
$1.03M -$2.05M -12,630 -67%
ACA
33
Atlas Capital Advisors
Wyoming
$972K
GJIC
34
Gamble Jones Investment Counsel
California
$972K
FTUS
35
Flow Traders U.S.
New York
$946K +$949K +5,835 New
PNC Financial Services Group
36
PNC Financial Services Group
Pennsylvania
$843K
SBH
37
Segall Bryant & Hamill
Illinois
$826K +$244K +1,500 +42%
AL
38
Aspiriant LLC
California
$743K -$11.2K -69 -1%
SC
39
Scotia Capital
Ontario, Canada
$660K +$75.1K +462 +13%
FNBOSM
40
First National Bank of South Miami
Florida
$627K -$20K -123 -3%
IAMOG
41
Investors Asset Management of Georgia
Georgia
$600K
Truist Financial
42
Truist Financial
North Carolina
$555K
FAAS
43
First Allied Advisory Services
California
$549K -$62.4K -384 -10%
WJWM
44
Williams Jones Wealth Management
New York
$512K -$56.9K -350 -10%
Bank of New York Mellon
45
Bank of New York Mellon
New York
$483K -$5.37K -33 -1%
TC
46
Telemus Capital
Michigan
$477K -$5.53K -34 -1%
PAG
47
Private Advisor Group
New Jersey
$471K
Cambridge Investment Research Advisors
48
Cambridge Investment Research Advisors
Iowa
$445K -$60.7K -373 -12%
Osaic Holdings
49
Osaic Holdings
Arizona
$379K -$8.94K -55 -2%
BPA
50
Beacon Pointe Advisors
California
$357K +$81.3K +500 +29%

BBH Hedge Fund Activity: Q3 2020 in Review

101 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2020, worth a combined $131M — up 1.6% from $129M a quarter earlier.

Fund positioning in BBH was balanced in Q3 2020: 12 funds opened new positions, 12 closed out, 24 added to existing stakes and 29 trimmed.

The largest buyer was Wealthspire Advisors (Maryland), opening a new position worth an estimated $1.18M. The largest seller was Envestnet Asset Management, cutting an estimated $2.05M.

  • 101 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2020, down from 102 in Q2 2020.
  • Funds reported $131M of VanEck Biotech ETF stock for Q3 2020, up 1.6% quarter-over-quarter.
  • 12 funds opened new VanEck Biotech ETF positions in Q3 2020 and 12 closed out, a net change of 0 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2020 was Wealthspire Advisors (Maryland), an estimated $1.18M added.
  • The largest VanEck Biotech ETF seller in Q3 2020 was Envestnet Asset Management, an estimated $2.05M sold.

Based on aggregated 13F filings for Q3 2020.